Research Article

SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia

Figure 1

SARS-CoV-2-specific T cell responses between baseline and follow-up. (a) T cell responses against spike S1 subunit at baseline and follow-up. (b) T cell responses against NMO at baseline and follow-up.
(a)
(b)